ARCHIVES

Steven Woolf: Why CMS Should Not Cover LDCT

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 25, 2003

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006

Diet/Nutrition Advisory Group Blast Fund Limit, Incurs Schmidt Wrath

February 4, 1977

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995